Dr Michael Wang on the Coming Precision Medicine Era in Mantle Cell Lymphoma

Risk Stratification of Mantle Cell LymphomaПодробнее

Dr. Wang on Precision Medicine in MCLПодробнее

Dr. Wang Discusses the Future of Treatment in MCLПодробнее

Limitations in Treating R/R Mantle Cell LymphomaПодробнее

Updates in Management of Mantle Cell LymphomaПодробнее

Michael Wang, MD, speculates on therapies for front-line and relapsed mantle cell lymphomaПодробнее

The Future of Treatment of Mantle Cell LymphomaПодробнее

Dr. Wang on Acalabrutinib Activity in Mantle Cell LymphomaПодробнее

Meet lymphoma expert Michael Wang, M.D.Подробнее

Zilovertamab vedotin in the treatment of mantle cell lymphomaПодробнее

Pre-clinical study shows MD Anderson-developed drug effective for mantle cell lymphoma treatmentПодробнее

Dr. Wang on CAR T-Cell Therapy Resistance in MCLПодробнее

Michael Wang, MD, shares details from the ZUMA-2 trial in mantle cell lymphoma presented at ASH 2019Подробнее

Dr. Wang on the Evolution of Treatment in MCLПодробнее

Dr Michael Wang Outlines Progress With Chemo-Free Therapies to Treat MCLПодробнее

Which patients with R/R MCL benefit from CAR-T therapy?Подробнее

Choosing Frontline Therapy for Mantle Cell LymphomaПодробнее

Dr Michael Wang on Finding Chemo-Free Therapies for MCLПодробнее

Dr. Wang Discusses the ZUMA-2 Trial in Mantle Cell LymphomaПодробнее